Sera prognostics CCO Lee Jr. sells $3,600 in stock

Dyaarl Lee Jr., the Chief Commercial Officer at SERA Prognostics, Inc. (NASDAQ:SERA), recently sold 1,800 shares of the company's Class A Common Stock on September 10, 2026. The transaction amounted to $3,600, with shares exchanged at prices between $2.00 and $2.03 each. This sale was categorized as a "sell to cover" transaction, intended to meet tax withholding requirements due to the vesting of restricted stock units (RSUs).

The move was not a discretionary one on Mr. Lee Jr.'s part. Following the sale, he now directly owns 76,198 shares of SERA's Class A Common Stock. The stock's current price is $2.03, a decline of approximately 31% year-to-date. However, InvestingPro analysis suggests the company might be undervalued at its present price. SERA currently has more cash than debt on its balance sheet, though it's spending cash rapidly.

For those interested, comprehensive Pro Research Reports and ProTips on SERA, one of 1,400+ US equities covered, are available on InvestingPro. In related news, SERA Prognostics released its second-quarter 2026 financial results, showing a larger-than-expected loss and revenue that fell short of analyst forecasts. The company reported an adjusted loss of $0.18 per share, surpassing the predicted $0.15 per share.

Revenue stood at $30,000, considerably lower than the anticipated $63,880. Despite this shortfall, SERA mentioned enhancements in testing volumes, payer interest, and clinical evidence, with a 76.5% increase in revenue compared to the same quarter last year. There were no reports of mergers or acquisitions or analyst upgrades or downgrades during this period.

These events underscore SERA's ongoing efforts to grow despite financial difficulties. This report was AI-generated and reviewed by an editor.